Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

17.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 82.00p
  • 52 Week Low: 16.25p
  • Currency: UK Pounds
  • Shares Issued: 95.31m
  • Volume: 151,287
  • Market Cap: £16.20m
  • RiskGrade: 410

Latest ShareCast News

Destiny Pharma reports progress on clinical assets

By Josh White

Date: Thursday 04 Jan 2024

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma said in a year-end update on Thursday that its primary focus remained on realising the full potential of its XF-73 Nasal asset.

Sunday share tips: Destiny Pharma, Invinity Energy Systems

By Alexander Bueso

Date: Sunday 29 Oct 2023

(Sharecast News) - The Financial Mail on Sunday's Midas column spied long-term potential in Destiny Pharma's shares.

Destiny Pharma loss widens as it extends cash runway

By Josh White

Date: Thursday 13 Apr 2023

(Sharecast News) - Biotechnology company Destiny Pharma reported a loss before tax of £7.7m in its 2022 results on Thursday, widening from £6.3m in the prior year.

Destiny Pharma upbeat on infection prevention st... 04-Apr-2023 ShareCast
Destiny publishes 'important' research on its pr... 24-Mar-2023 ShareCast
Destiny Pharma jumps on 2022 progress 22-Dec-2022 ShareCast
Destiny Pharma finalises plans for next study of... 07-Dec-2022 ShareCast
Destiny Pharma starts new safety study of dermal... 15-Nov-2022 ShareCast
Destiny Pharma gets positive feedback from EMA o... 07-Sep-2022 ShareCast
Destiny Pharma awarded Cystic Fibrosis Foundatio... 12-Jul-2022 ShareCast
Destiny Pharma appoints Yuri Martina as chief me... 03-May-2022 ShareCast
Destiny Pharma to raise up to £7m in discounted ... 08-Mar-2022 ShareCast
Destiny upbeat on nasal gel feedback from EMA 08-Feb-2022 ShareCast
Destiny successfully completes preclinical study... 01-Feb-2022 ShareCast
Destiny Pharma reports success in US C. diff trial 24-Jan-2022 ShareCast
Destiny Pharma upbeat on recent study into mupir... 18-Oct-2021 ShareCast
Destiny Pharma's China partner starts new XF-73 ... 27-Sep-2021 ShareCast
Destiny Pharma reports positive secondary data o... 02-Aug-2021 ShareCast
Destiny Pharma inks research deal with US Vetera... 06-Jul-2021 ShareCast
Destiny Pharma reports positive progress on lead... 02-Jun-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 17.00p
Change Today -0.50p
% Change -2.86 %
52 Week High 82.00p
52 Week Low 16.25p
Volume 151,287
Shares Issued 95.31m
Market Cap £16.20m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.11% below the market average21.11% below the market average21.11% below the market average21.11% below the market average21.11% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Destiny Pharma Dividends

No dividends found

Trades for 10-May-2024

Time Volume / Share Price
16:19 30 @ 17.50p
16:19 15,000 @ 17.01p
12:39 30,000 @ 17.09p
12:29 3,509 @ 17.24p
12:26 285 @ 17.50p

Destiny Pharma Key Personnel

CEO Chris Tovey

Top of Page